title: Immunoisolation of Human or Xenogeneic Insulin-Producing Cells: The Next Step for Treating Patients With Type 1 Diabetes?
authors.affiliation: 1 Division of Experimental Surgery and Transplantation (CHEX), Université Catholique de Louvain, Institute of Experimental and Clinical Research (IREC), Brussels, Belgium. 2 Transplant Immunology Unit, Padua University Hospital, Padua, Italy. 3 CORIT (Consortium for Research in Organ Transplantation), Padua, Italy.
authors.forename: Pierre
authors.initials: P
authors.lastname: Gianello
authors.forename: Nizar I
authors.initials: NI
authors.lastname: Mourad
authors.forename: Emanuele
authors.initials: E
authors.lastname: Cozzi
mesh_terms: D003922:Diabetes Mellitus, Type 1; D006801:Humans; D007328:Insulin; D050417:Insulin-Secreting Cells; D061385:Insulins; D016381:Islets of Langerhans Transplantation
chemical_list: D007328:Insulin; D061385:Insulins